Literature DB >> 26215679

Should cost considerations be included in medical decisions? No.

Bin Du1, Jeremy M Kahn2.   

Abstract

Mesh：

Year:  2015        PMID： 26215679     DOI： 10.1007/s00134-015-3954-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.

Authors:  Robert A Fowler; Nicole Mittmann; William Geerts; Diane Heels-Ansdell; Michael K Gould; Gordon Guyatt; Murray Krahn; Simon Finfer; Ruxandra Pinto; Brian Chan; Orges Ormanidhi; Yaseen Arabi; Ismael Qushmaq; Marcelo G Rocha; Peter Dodek; Lauralyn McIntyre; Richard Hall; Niall D Ferguson; Sangeeta Mehta; John C Marshall; Christopher James Doig; John Muscedere; Michael J Jacka; James R Klinger; Nicholas Vlahakis; Neil Orford; Ian Seppelt; Yoanna K Skrobik; Sachin Sud; John F Cade; Jamie Cooper; Deborah Cook
Journal:  JAMA       Date:  2014-11-26       Impact factor: 56.272

2.  Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2008-11-06       Impact factor: 91.245

3.  Cost awareness of physicians in intensive care units: a multicentric national study.

Authors:  Romain Hernu; Martin Cour; Sylvie de la Salle; Dominique Robert; Laurent Argaud
Journal:  Intensive Care Med       Date:  2015-05-22       Impact factor: 17.440

4.  ICU bed supply, utilization, and health care spending: an example of demand elasticity.

Authors:  Rebecca A Gooch; Jeremy M Kahn
Journal:  JAMA       Date:  2014-02-12       Impact factor: 56.272

5.  The argument against reimbursing physicians for value.

Authors:  Lara Goitein
Journal:  JAMA Intern Med       Date:  2014-06       Impact factor: 21.873

6.  An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine policy statement: the Choosing Wisely® Top 5 list in Critical Care Medicine.

Authors:  Scott D Halpern; Deborah Becker; J Randall Curtis; Robert Fowler; Robert Hyzy; Lewis J Kaplan; Nishi Rawat; Curtis N Sessler; Hannah Wunsch; Jeremy M Kahn
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

Review 7.  Physicians, cost control, and ethics.

Authors:  D P Sulmasy
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

8.  Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

Review 9.  Critical care and the global burden of critical illness in adults.

Authors:  Neill K J Adhikari; Robert A Fowler; Satish Bhagwanjee; Gordon D Rubenfeld
Journal:  Lancet       Date:  2010-10-11       Impact factor: 79.321

10.  A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK.

Authors:  Karin Bruynesteyn; Vanya Gant; Catherine McKenzie; Tony Pagliuca; Chris Poynton; Ritesh N Kumar; Jeroen P Jansen
Journal:  Eur J Haematol       Date:  2007-04-05       Impact factor: 2.997
View more
  3 in total

1.  Should cost considerations be included in medical decisions? Not so sure….

Authors:  Maurizia Capuzzo; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2015-07-28       Impact factor: 17.440

Review 2.  [Specialized neurological neurosurgical intensive care medicine].

Authors:  J B Kuramatsu; H B Huttner; S Schwab
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

3.  Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis.

Authors:  Frode Lindemark; Øystein A Haaland; Reidar Kvåle; Hans Flaatten; Ole F Norheim; Kjell A Johansson
Journal:  Crit Care       Date:  2017-08-21       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.